These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26799527)

  • 21. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H; Iyo M; Hashimoto K
    Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Running wheel exercise before a binge regimen of methamphetamine does not protect against striatal dopaminergic damage.
    O'dell SJ; Marshall JF
    Synapse; 2014 Sep; 68(9):419-25. PubMed ID: 24899064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-Dependent Changes in Striatal Dopamine Transport in Preadolescent Rats Exposed Prenatally and/or Postnatally to Methamphetamine.
    Sirova J; Kristofikova Z; Vrajova M; Fujakova-Lipski M; Ripova D; Klaschka J; Slamberova R
    Neurochem Res; 2016 Aug; 41(8):1911-23. PubMed ID: 27038442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.
    Chu PW; Hadlock GC; Vieira-Brock P; Stout K; Hanson GR; Fleckenstein AE
    J Neurochem; 2010 Oct; 115(2):325-32. PubMed ID: 20649837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways.
    Bourque M; Dluzen DE; Di Paolo T
    Neuropharmacology; 2012 Jun; 62(7):2363-72. PubMed ID: 22369785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain.
    Yu J; Allison S; Ibrahim D; Cadet JL; Angulo JA
    Ann N Y Acad Sci; 2002 Jun; 965():247-53. PubMed ID: 12105100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
    Truong JG; Wilkins DG; Baudys J; Crouch DJ; Johnson-Davis KL; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1087-92. PubMed ID: 15901804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
    McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
    Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance to the neurotoxic effects of methamphetamine in young rats.
    Riddle EL; Kokoshka JM; Wilkins DG; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2002 Jan; 435(2-3):181-5. PubMed ID: 11821024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotoxic methamphetamine regimens produce long-lasting changes in striatal G-proteins.
    Boikess SR; O'Dell SJ; Marshall JF
    Synapse; 2010 Nov; 64(11):839-44. PubMed ID: 20336628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic stress augments the long-term and acute effects of methamphetamine.
    Matuszewich L; Yamamoto BK
    Neuroscience; 2004; 124(3):637-46. PubMed ID: 14980734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study.
    Booij J; de Bruin K; Gunning WB
    Nucl Med Biol; 2006 Apr; 33(3):409-11. PubMed ID: 16631090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?
    Hanson GR; Gibb JW; Metzger RR; Kokoshka JM; Fleckenstein AE
    Ann N Y Acad Sci; 1998 May; 844():103-7. PubMed ID: 9668668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen, testosterone, and methamphetamine toxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2006 Aug; 1074():282-94. PubMed ID: 17105924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide mitagates methamphetamine-induced striatal dopamine depletion via modulating local TNF-alpha and dopamine transporter expression.
    Lai YT; Tsai YP; Cherng CG; Ke JJ; Ho MC; Tsai CW; Yu L
    J Neural Transm (Vienna); 2009 Apr; 116(4):405-15. PubMed ID: 19271121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
    Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
    Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.